Expion360 Inc. (XPON) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Expion360 Inc., a Nevada corporation, on January 29, 2026. The Company's common stock trades on The Nasdaq Capital Market under the symbol "XPON." The filing addresses a regulatory notice received from Nasdaq regarding the Company's continued listing status.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the trading price of the Common Stock, which closed below the $1.00 minimum bid price requirement for 30 consecutive business days prior to January 29, 2026.
Material Changes
On January 29, 2026, the Company received a Staff Determination from Nasdaq stating that its securities are subject to delisting due to failure to meet the Minimum Bid Price Requirement (Rule 5550(a)(2)). This represents a material change in the Company's listing status, triggering a compliance period.
Guidance, Outlook, and Risks
- Compliance Period: Nasdaq has granted an initial 180-calendar-day compliance period, ending July 28, 2026, to regain compliance with the $1.00 minimum bid price.
- Future Options: If the Company fails to regain compliance by the initial deadline, it may be eligible for an additional 180-day period if it meets other listing standards (excluding bid price) and provides written notice of intent to cure, potentially via a reverse stock split.
- Management Intent: The Company is evaluating options to regain compliance and intends to do so timely, though there is no assurance of success.
- Risks: The filing includes a cautionary note regarding forward-looking statements, highlighting risks related to the trading price of the Common Stock and the uncertainty of maintaining Nasdaq listing standards.
Investor Verification Checklist
- Verify the current trading price of XPON to assess the gap from the $1.00 minimum bid price.
- Review the Company's most recent Form 10-K and 10-Q for detailed financial health and risk factors.
- Monitor future announcements regarding the Company's plan to cure the deficiency (e.g., reverse stock split proposals).
- Confirm the Company's market value of publicly held shares to determine eligibility for a second compliance period if needed.